Announcements Trials
Browse Landscape

Status

Not yet recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 53Observational 3Expanded_access 2

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 2Plasma cell 1Myeloid 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 397Leukemia, Lymphocytic, Chronic, B-Cell 215Lymphoma, Non-Hodgkin 203Lymphoma, Follicular 193Lymphoma, Large B-Cell, Diffuse 180Leukemia 164Hodgkin Disease 160Multiple Myeloma 118Neoplasms 97Leukemia, Myeloid, Acute 87Lymphoma, Mantle-Cell 78Burkitt Lymphoma 66Myelodysplastic Syndromes 64Lymphoma, B-Cell, Marginal Zone 64Lymphoma, T-Cell, Cutaneous 62Breast Neoplasms 62Mycosis Fungoides 55Recurrence 52Lymphoma, B-Cell 50Hematologic Neoplasms 50Sezary Syndrome 43Waldenstrom Macroglobulinemia 41Myeloproliferative Disorders 39Neoplasms, Plasma Cell 38Lung Neoplasms 34Lymphoma, Large-Cell, Immunoblastic 33Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 32Leukemia, Hairy Cell 29Lymphoma, T-Cell, Peripheral 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Immune System Diseases × Lymphoid × Clear all
NCT04996706 2026-05-26

LEO

Mayo Clinic

Enrolling by invitation
21,000 enrolled
Lymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type

NCT05969821 2026-03-23

CHIS

Assistance Publique - Hôpitaux de Paris

Not yet recruiting
5,000 enrolled
LymphoidMyeloidOther hematologic neoplasm

VEXAS syndrome, Autoimmune Diseases, Hematologic Diseases, Immune System Diseases, Inflammation, Leukemia, Lymphoma, Lymphoproliferative Disorders, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases

NCT04830046 2025-11-26

Covid-19 Vaccine Responsiveness in MM and Waldenstrom

Massachusetts General Hospital

Completed
146 enrolled
LymphoidPlasma cell

COVID-19, Immune System Diseases, Waldenstrom Macroglobulinemia, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡